Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Product/Service, Trade Show

Cortexyme to Present Additional Top-line GAIN Trial Results and Analysis at CTAD 2021 on November 11th

Cortexyme, Inc. (Nasdaq: CRTX) announced that it will participate at the 14th Clinical Trials on Alzheimer's Disease Conference (CTAD 2021) as a part of the meeting's Late-Breaking Readout Roundtable program on Thursday, November 11, 2021, at 11:35 a.m. Eastern Time in Boston, Massachusetts. During the company's 30-minute presentation, Cortexyme's chief medical officer Michael Detke, MD, PhD, and GAIN Trial lead investigator Marwan Sabbagh, MD, FAAN, will provide additional GAIN Trial top-line results and analysis.

CTAD 2021 Late-Breaking Readout Roundtable Details

Title: Top-line Results from the GAIN Trial: A Phase 2/3 Study of Atuzaginstat in Mild to Moderate Alzheimer's Disease.

1Cortexyme - South San Francisco, CA (USA), 2Barrow Neurological Institute, Dignity Health/St. Joseph's Hospital and Medical Center - Phoenix, AZ (USA), 3UCSF - San Francisco, CA (USA), 4Innovative Analytics - Portage, MI (USA), 5Datafy Clinical R&D - Portage, MI (USA), 6Pentara Corporation - Millcreek, UT (USA), 7Forsyth Institute - Cambridge, MA (USA)

About Cortexyme

Cortexyme, Inc. (Nasdaq: CRTX) is a clinical stage biopharmaceutical company pioneering upstream therapeutic approaches designed to improve the lives of patients diagnosed with Alzheimer's and other degenerative diseases. Cortexyme's lead program targets a specific, infectious pathogen called P. gingivalis found in the brain of Alzheimer's patients and other organs and tied to degeneration and inflammation in humans and animal models. The company's causation evidence for Alzheimer's disease and the mechanism of its novel therapeutic has been independently replicated and confirmed by multiple laboratories around the world, as well as published in peer-reviewed scientific journals. To learn more about Cortexyme, visit www.cortexyme.com or follow @Cortexyme on Twitter.

These press releases may also interest you

at 17:35
Revelian, a leader in the field of emotional intelligence and game-based assessments, announced today that it has rebranded as Criteria. Criteria, a market-leading SaaS talent success platform with headquarters in Los Angeles, California, acquired...

at 16:05
Megaport Limited ("Megaport"), a global leading Network as a Service (NaaS) provider, today announces plans to expand services to Mexico via a partnership with KIO Networks, the country's largest data centre provider. Cloud connectivity services to...

at 10:30
The Vulnerability Management will grow at a CAGR of 8.98% by 2025. This report offers key advisory and intelligence to help buyers identify and shortlist the most suitable suppliers for their Vulnerability Management requirements....

at 10:00
Tidel, a world leader in cash automation systems for the retail marketplace, today announced the TR180, a next generation retail cash recycler offering an unparalleled combination of performance, ergonomics, and configurability, all in a fully...

at 03:00
Powerbridge Technologies Co., Ltd. ("Powerbridge" or the "Company"), a SaaS solutions and Blockchain applications provider, today announced that it has received a notification letter (the "Notification Letter") from the Nasdaq Stock Market LLC (the...

at 02:00
From the 18th to midnight (UTC+8) on the 25th of January, investors depositing Inflation Hedging Coin (IHC) tokens on the X-Meta Exchange (x-meta.com) will be eligible for an exclusive reward of 5% of the total amount of IHC tokens they deposit. The...

News published on 4 november 2021 at 08:10 and distributed by: